Table 3 |.
Cell type | Differentiation cell type | Species | Pluripotent stem cell type | scRNA-seq method | Refs |
---|---|---|---|---|---|
Pluripotent stem cells | Reprogramming of CD19+ pre-B cells to iPSCs | Mouse | iPSC reprogramming | MARS-seq | 146 |
Undifferentiated iPSCs | Human | iPSC | 10× Genomics 3ʹ | 147 | |
Differentiated cells | Cardiomyocytes | Human | iPSC | 10× Genomics 3ʹ | 104 |
Cardiomyocytes | Human | iPSC | 10× Genomics 3ʹ | 103 | |
Endothelial cells | Human | ESC (KhES1) | Smart-seq | 148 | |
Endothelial cells | Human | iPSC | 10× Genomics 3ʹ | 63 | |
Endothelial cells | Human | ESC (H9 and RC11) | 10× Genomics 3ʹ | 106 |
ESC, embryonic stem cell; iPSC, induced pluripotent stem cell; MARS-seq, massively parallel single-cell RNA-sequencing; scRNA-seq, single-cell RNA sequencing; Smart-seq, switching mechanism at the 5′ end of the RNA template sequencing.